首页> 中文期刊> 《中国医院用药评价与分析》 >2015-2017年某三级甲等医院中药注射剂应用分析

2015-2017年某三级甲等医院中药注射剂应用分析

         

摘要

OBJECTIVE: To investigate the application status of traditional Chinese medicine (TCM) injections in a Grade Ⅲ Level A hospital (hereinafter referred to as "the hospital"), and to probe into the effects of zero-price policy on the use of TCM injections in the hospital since 2017, so as to provide reference for the rational drug application in clinic. METHODS: The application data of TCM injections in the hospital during 2015-2017 were retrospectively analyzed, and the categories, consumption sum, defined daily dose system (DDDs), defined daily cost (DDC), ranking of consumption sum/DDDs, and occurrence of adverse drug reactions were statistically analyzed. RESULTS: After the implementation of zero-price policy, the consumption sum, DDDs and DDC of TCM injections in the hospital were all lower than before. In the past 3 years, the consumption sum of blood circulation, Yiqi Fuzheng and anti-tumor TCM injections took the top 3 places, and the consumption sum of Shenfu injection, Shuxuetong injection and Xiyanping injection had good synchronization with the DDDs. CONCLUSIONS: The zero-price policy of drugs has effects on the application of TCM injections, yet such drugs are still widely used in clinical practice. Therefore, it is necessary for hospitals to strengthen drug management and improve the safety, effectiveness and economy of clinical drugs.%目的:了解某三级甲等医院(以下简称"该院")中药注射剂使用情况,了解2017年开始实施的药品零差价政策对该院中药注射剂使用的影响,为临床合理用药提供参考.方法:回顾性调查2015-2017年该院中成药注射剂的使用数据,对品种、销售金额、用药频度、限定日费用、销售金额排序/用药频度排序及药品不良反应发生情况进行统计分析.结果:实施药品零差价后,该院中药注射剂的销售金额、用药频度及限定日费用均较前减少;3年来,活血化瘀类、益气扶正类和抗肿瘤类中药注射剂的销售金额排序居前3位,参附注射液、疏血通注射液和喜炎平注射液的销售金额与用药频度的同步性较好.结论:药品零差价政策对中药注射剂的使用存在影响,但该类药物仍在临床上广泛应用,医院有必要加强用药管理,提高临床用药安全性、有效性和经济性.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号